Preprint · CC-BY
via OpenAlex
Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR
Xiaofeng Feng, Jianying Pan, Junyan Li, Chun Zeng, Weizhong Qi, Yan Xia Shao, Xin Liu, Liangliang Liu, Guozhi Xiao, Haiyan Zhang, Xiaochun Bai, Daozhang Cai
Aging · 2020 · ▲ 124 citations
Abstract
BACKGROUND: It is generally thought that the occurrence and progression of osteoarthritis (OA) results from multiple causes, including degradation and destruction of the cartilage matrix and aging of chondrocytes. Metformin is a first-line drug for the treatment of diabetes, and has great potential for the treatment of other disorders. However, the role of metformin in OA is unknown. RESULTS: levels in OA chondrocytes, and enhanced polarization of AMPK and inhibition of mTORC1 in OA mice and chondrocytes in a dose-dependent manner. CONCLUSIONS: Metformin effectively alleviated cartilage degradation and aging through regulation of the AMPK/mTOR(definition) signaling pathways, suggesting that it could be an effective treatment for OA. METHODS: The effects of metformin on cartilage degradation and chondrocyte aging was determined in a destabilization of the medial meniscus (DMM)-induced OA mouse model and in IL-1β-treated mouse chondrocytes and cartilage explants. Articular cartilage degeneration was graded using the Osteoarthritis Research Society International (OARSI) criteria. Immunostaining, RT-PCR, and western blot analyses were conducted to detect the relative expressions of protein and RNA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/aging.102635
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Feng, X., Pan, J., Li, J., Zeng, C., Qi, W., Shao, Y.X., Liu, X., Liu, L., Xiao, G., Zhang, H., Bai, X., & Cai, D. (2020). Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR. <em>Aging</em>. https://doi.org/10.18632/aging.102635
Vancouver
Feng X, Pan J, Li J, Zeng C, Qi W, Shao YX, et al. Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR. Aging. 2020. doi:10.18632/aging.102635.
BibTeX
@unpublished{xiaofeng2020Metfor,
title = {Metformin attenuates cartilage degeneration in an experimental osteoarthritis model by regulating AMPK/mTOR},
author = {Xiaofeng Feng and Jianying Pan and Junyan Li and Chun Zeng and Weizhong Qi and Yan Xia Shao and Xin Liu and Liangliang Liu and Guozhi Xiao and Haiyan Zhang and Xiaochun Bai and Daozhang Cai},
journal = {Aging},
year = {2020},
doi = {10.18632/aging.102635},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Arthritis Research & Therapy 2020
Open access · CC-BY
Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior
Osteoarthritis and Cartilage 2025
Open access · CC-BY
Imeglimin, a novel antidiabetic agent related to metformin, attenuates knee osteoarthritis development and progression through AMPK activation and NF-κB signaling inhibition
Research Square 2023
Preprint · CC-BY
Fisetin suppresses chondrocyte senescence and attenuates osteoarthritis progression by targeting SIRT6
CRC Press eBooks 2025
Citation only
Senolytics
Aging 2026
Open access · CC-BY
Metformin at the convergence of aging and longevity
PLoS ONE 2012
Open access · CC-BY